Dashboard
Financial statements
RVTY

Company financials

Revvity

Health Care Health Care Equipment Waltham, Massachusetts Last filing Feb 24, 2026 · FY2025
Revenue FY2025
$2.9B
3y CAGR -4.8% P7
Net income FY2025
$241.2M
Net margin +8.4% P37
Total assets FY2025
$12.2B
ROA +2.0% P12
Operating cash flow FY2025
$582.9M
FCF margin +17.8% P61
18 yrs · FY2008–FY2025 9 filed · 0 derived · 0 blank

Year-over-year change per cell; first column has no prior.

Balance Sheet

Assets, liabilities, and equity

31 accounts · 5 years
Total assets $12.2B
Total liabilities $4.9B
Shareholders equity $7.3B
Account 2025 2024 2023 2022 2021 Trend
Assets
Cash and Cash Equivalents -20.9% +27.4% +101.0% -24.7%
Accounts Receivable +17.8% -0.1% +3.3% -13.4%
Inventory
Prepaid Expenses
Other Current Assets
Total Current Assets -4.7% -21.7% -8.7% +34.7%
Property,Plant and Equipment -0.6% -5.4% +5.5% -0.5%
Operating Lease Assets -1.4% +8.1% -17.7% +14.8%
Goodwill +2.3% -1.1% +0.8% -2.2%
Intangible Assets
Other Noncurrent Assets +12.2% -15.9% +10.3% -1.9%
Total Assets -1.8% -8.6% -4.0% -5.8%
Liabilities
Accounts Payable +10.7% -18.0% -25.2% -16.0%
Accrued Liabilities +14.7% -7.5% -0.6% -22.3%
Deferred Revenue
Current Portion of Long Term Debt
Operating Lease Liabilities
Other Current Liabilities
Total Current Liabilities +103.8% -55.0% -6.1% +27.2%
Long Term Debt -16.5% -0.9% -19.0% -21.2%
Deferred Revenue Noncurrent
Operating Lease Liabilities Noncurrent -2.2% +14.1% -21.9% +15.3%
Other Noncurrent Liabilities +4.8% -17.2% -16.1% -22.3%
Total Liabilities +4.1% -17.0% -15.6% -14.2%
Equity
Preferred Stock
Common Stock -6.9% -2.3% -2.3% +0.0%
Additional Paid In Capital -37.7% -13.2% -12.2% -0.3%
Retained Earnings
Accumulated Other Comprehensive Income
Total Stockholders Equity -5.4% -2.6% +6.6% +3.4%
Total Liabilitiesand Equity -1.8% -8.6% -4.0% -5.8%

Key Ratios

Margins, returns, liquidity, leverage, efficiency

Computed at import · 5 years
Ratio 2025 2024 2023 2022 2021
Profitability
Gross margin
Operating margin +12.5% +12.6% +10.9% +22.4% +32.9%
Net margin +8.4% +9.8% +25.2% +17.2% +24.6%
FCF margin +17.8% +21.0% +0.4% +17.7% +32.5%
Growth
Revenue CAGR (3y) -4.8% -10.4% +1.1% +4.7% +11.3%
Returns
ROE +3.3% +3.5% +8.8% +7.7% +13.2%
ROA +2.0% +2.2% +5.1% +4.0% +6.3%
ROIC +3.3% +3.6% +2.7% +6.6% +10.9%
Liquidity
Current ratio 1.68x 3.60x 2.07x 2.13x 2.01x
Quick ratio 1.25x 2.75x 1.07x 0.69x 1.08x
Leverage
D/E 0.68x 0.62x 0.72x 0.91x 1.10x
Interest coverage 3.87x 3.04x
Efficiency
Asset turnover 0.23x 0.22x 0.20x 0.23x 0.26x
Cash conversion cycle

Valuation

Price against fundamentals

FY2025 fundamentals · no price

No price data cached, so there is nothing to multiply. Load prices from the Stock Data tab and this panel reprices itself.

Notes

Your annotations

Not watched
Saving notes adds RVTY to your watchlist.